SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Alteon (ALT)
An SI Board Since April 1996
Posts SubjectMarks Bans Symbol
318 10 0 ALT
Emcee:  Catherine Type:  Unmoderated
Introduction Market Data Compact
Looking for information on ALTN. Have heard they are up and coming with
many products in the pipeline. Can anyone elaborate?
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
318Alteon Notified by AMEX of Acceptance of Plan of Compliance Regarding Continued creede-2/1/2007
317Alteon and HaptoGuard Shareholders Approve Merger Wednesday July 19, 4:05 pm ET tnsaf-8/13/2006
316Alteon and HaptoGuard Announce Merger Agreement; Alteon Signs Agreements for Salsim1-4/20/2006
315slow motion.... let's see what is going on around .33 or so eomotherbrotherdaryl-1/30/2006
314Jason..... A couple setups only a very few technicians know about. No promisesotherbrotherdaryl-12/26/2005
313Care to say what is interesting?tnsaf-12/25/2005
312Has an increasingly interesting chart. I'm in.otherbrotherdaryl-12/25/2005
311Alteon Updates Investors on Alagebrium Development Status Wednesday May 4, 9:40 tnsaf-5/5/2005
310Alteon's Investigational Drug Alagebrium Demonstrates Beneficial Effects on tnsaf-5/25/2004
309Alteon Initiates 'SPECTRA,' Trial of Alagebrium Chloride (ALT-711) In Patnsaf-3/10/2004
308Alteon's ALT-711 Shows Highly Significant Reduction in Systolic Blood Pressutnsaf-2/23/2004
307Tuesday March 5, 11:25 am Eastern Time Press Release SOURCE: Alteon Inc. Alteon tnsaf-3/6/2002
306Alteon Announces Issuance of Key Patent Covering Glucose Lowering Agents, Addititnsaf-12/10/2001
305Alteon Announces Initiation of Phase I Human Testing of ALT-711 In ESRD Patientstnsaf-11/21/2001
304Alteon Initiates Second Phase IIb Trial of ALT-711 in Systolic Hypertension - Cotnsaf-11/21/2001
303Alteon's ALT-711 Found to 'Remodel' Cardiovascular System in Preclintnsaf-11/21/2001
302Wednesday September 5, 11:29 am Eastern Time Press Release SOURCE: Alteon Inc. Atnsaf-9/5/2001
301New Study Links Glucose/Protein Complexes (A.G.E.s) and Alzheimer's Disease tnsaf-8/7/2001
300Monday July 9, 9:11 am Eastern Time Press Release SOURCE: Alteon Inc. Alteon Initnsaf-7/17/2001
299<i> Results also show a clinically relevant increase in large artery complscott_jiminez-1/4/2001
298Wednesday January 3, 7:45 am Eastern Time Press Release SOURCE: Alteon Inc. Atnsaf-1/3/2001
297Two news releases, excluding the "about Alteon" stuff... Tuesday Decetnsaf-12/6/2000
296Wednesday November 29, 10:23 am Eastern Time Press Release SOURCE: BioStratum tnsaf-11/29/2000
295Monday November 27, 9:00 am Eastern Time Press Release SOURCE: Alteon Inc. Phtnsaf-11/27/2000
294Two news releases from the past few weeks. Jason <i> Tuesday October 1tnsaf-11/5/2000
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News